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Stocks of vesicular stomatitis virus free of defective interfering particles were pro-
duced by serial clonal isolation. High-multiplicity infections with these stocks led to
no interference or formation of defective interfering particles. Defective interfering
particles were generated by three successive passages at high multiplicity.
Replication of the Indiana serotype of vesicular
stomatitis virus (VSV) produces standard plaque-
forming B particles and defective interfering
(DI) particles (5, 8, 11). The major DI particle
found in our stocks is one-third the length of
standard B particles and is referred to below as
DI-T rather than "T particles" as has been the
previous convention (8). Previous work has
shown that the sucrose gradient pattern of
ribonucleic acid (RNA) species synthesized by
cells infected with VSV varies, depending upon
the amount of DI-T present (12). In the absence
of interfering particles, the predominant effects
are synthesis of B particles and of group I RNA
species (mainly 28S and 13S RNA). When cells
are co-infected with DI-T and B, synthesis of
DI-T and group II RNA (mainly 19S and 6S)
predominates. High-multiplicity infections with
B particles purified by rate zonal centrifugation
will also yield group II RNA and DI-T.
Production of DI-T and group II RNA species
at high multiplicities could be either an intrinsic
property of cells multiply infected by B particles
or the result of contamination by undetectable
amounts of DI-T in B preparations leading to co-
infection of cells by DI-T and its helper, standard
virus. To distinguish between these possibilities,
several clonal plaque isolations of VSV have
been made. Because initial passages appeared to
be free ofDI particles, successive high-multiplicity
passages were analyzed for the production of
DI particles. To detect DI yields in this study,
we used radioactive labeling and separation
on sucrose gradients, as well as analysis of the
species of RNA produced in infected cells. A
typical clonal isolation of B particles and the
1 Present address: Channing Laboratory, Boston City Hospital,
Boston, Mass. 02118.
initial detection of DI particles are presented
here. Repetition of this procedure has led to
similar results.
To isolate cloned preparations of VSV, a
monolayer of Chinese hamster ovary (CHO)
cells infected with 6 plaque-forming units (PFU)
of VSV was overlaid with agar as previously
described (12). A well isolated plaque of ap-
proximately 1.5 mm in diameter was picked by
inserting a capillary tube into the agar directly
above the plaque, withdrawing the capillary
tube, and blowing the occluded agar into 1 ml of
medium. After disrupting the agar by using a
vortex supermixer, the solution was diluted and
assayed for plaques on fresh, CHO cell mono-
layers. This plaque isolation was repeated four
successive times.
To build up an initial stock of this plaque-
purified VSV with minimal cross-infection of the
cells, four CHO cell monolayer cultures on 60-
mm plastic petri dishes were each infected with
200 PFU of virus from the fifth successive iso-
lation. After 1 day, when most of the plaques
were not overlapping, virus was harvested by
collecting the agar overlay from each of the four
plates. Each plate was then rinsed with 1 ml of
medium. This medium and 5 ml of fresh medium
were combined with the agar, and the suspension
was centrifuged at 27,000 X g at 4 C for 10 min
in the Sorvall RC2-B centrifuge. This procedure
concentrated the agar, and a total of 15 ml of
supernatant was collected which contained 108
PFU/ml. From this initial stock, another passage
of VSV was made by infecting suspended CHO
cells at a multiplicity of 0.4 PFU per cell and
harvesting the virus at 7.5 hr after infection.
This diluted passage was then used for the fol-
lowing infections at high multiplicities. Details
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of VSV infections and growth of CHO cells
have been described (12).
To determine the species of viral RNA and
types of VSV particles synthesized at high mul-
tiplicities, suspended CHO cells were infected
for three successive passages at multiplicities of
100, 50, and 50, respectively. After each infec-
tion, labeled viral particles from the medium
and viral RNA from the cytoplasm were ana-
lyzed by sucrose gradient centrifugation as previ-
ously described (12). Under these conditions of
infection, incorporation of radioactive uridine
into virus-specific RNA was complete by 5 hr
after infection, and production of viral particles
ceased by 6 to 7 hr after infection. Unlabeled
infected cells, harvested in parallel with the
labeled cells, provided virus for the subsequent
passage. The first high-multiplicity passage
yielded 1.5 X 109 PFU/ml, the second 7.3 x
108 PFU/ml, and the third 7.8 X 107 PFU/ml.
The decrease in VSV titer after the third suc-
cessive high-multiplicity passage shows the in-
terference phenomenon which was first described
by Bellett and Cooper in 1959 (2).
The VSV particles produced during the three
high multiplicity passages and the species of viral
RNA which were synthesized are shown in
Fig. 1. In the first passage at a multiplicity of
100, only the group I cytoplasmic RNA species
were detected (Fig. la), and only labeled stan-
dard B virions were made (Fig. ld). This shows
that high-multiplicity infections can be carried
out with purified B preparations in the absence
of detectable DI production. In the second
passage, at a multiplicity of 50, again only group I
RNA species were present in the cytoplasm
(Fig. lb), and labeled B particles were found in
the supernatant (Fig. le) along with some B
aggregates sedimenting ahead of the main peak.
During the third successive passage, at a mul-
tiplicity of 50, extensive production of group II
RNA species, as well as some group I species,
was observed (Fig. ic). Also, RNA between
19S and 28S was present which had not been
seen previously (12). Labeled particles produced
during the third passage gave a heterogeneous
distribution with peaks in the regions expected
for standard B, as well as what appears to be
shorter defective particles (Fig. lf). If, during the
third successive passage, co-infection of cells
was reduced by using a multiplicity of one or
less, the results resembled those seen during the
first high-multiplicity passage. Therefore, it is
most likely that DI particles are detectable by
the third high-multiplicity passage because of
coinfection of cells with standard virus and DI
particles which were presumably generated in
undetectable amounts during the first and second
high-multiplicity passages. However, we cannot
rule out the possibility that the third high-mul-
tiplicity passage differs in some indeterminate
way from the first and second by its ability to
generate large amounts of DI.
The heterogeneity of the viral particles pro-
duced after the third high-multiplicity passage
and the markedly reduced yield in virus titer
indicated that DI particles were generated.
Although these results and similar results ob-
tained by Crick et al. (4) do not yield an ab-
solute number for the frequency of appearance
of DI particles among a population of VSV,
the rate of generation of DI particles is similar
to reovirus where DI particles are detected upon
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FIG. 1. Sucrose gradient patterns of viral RNA
species and types of VSV particles synthesized in
three successive high-multiplicity passages with
clonally purified VSV. Suspensions of CHO cells
at 4 X 106/ml were infected with purified B, and 10
,ug/ml actinomycin D was added. After a 30-min
attachment period, cells were diluted twofold and ex-
posed to 0.3 ,uCi of 14C-uridine/ml (New England
Nuclear Corp., Boston, Mass., 55.6 mCi/mM). At
7.5 hr postinfection the cells were harvested to obtain
the cytoplasmic extract and the released viral par-
ticles. For panels (e) and (f), viral particles were
obtained by centrifugation of the medium as previously
described (10). For panel (d), the cell-free medium,
was layered directly on the sucrose gradient. The
data in each panel represent acid-precipitable radio-
activity from 107 cells. (a) and (d) First passage at a
multiplicity of 100 PFU/cell; (b) and (e) second
passage at a multiplicity of 50 PFU/cell; (c) and (f)
third passage at a multiplicity of 50 PFU/cell.
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the third or fourth successive high-multiplicity
passages after clonal isolations (10). In contrast,
poliovirus requires 18 successive high-multiplicity
passages to generate detectable levels of DI
particles (C. N. Cole, D. Smoler, E. Wimmer,
and D. Baltimore, J. Virol., in press). How-
ever, it should be noted that in certain cells
successive high-multiplicity passages do not lead
to progressive interference for influenza (3),
VSV (6), or Sendai virus (9).
Data from the first passage show that a high-
multiplicity passage per se with VSV does not
result in the production of large amounts of
DI particles and that the stock used to initiate
the high-multiplicity passages was free of de-
tectable DI particles. Thus, biochemical experi-
ments (7) can be performed with VSV without
any interference at high multiplicities if the first
few passages from clonally purified virus are
used. Furthermore, very high titer VSV stocks
(1) can be grown using virus from the early
passages.
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